Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP7 | O15540 | 1/20 | 0.47 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.35 |
| ▸ | CHRNG | P07510 | 1/20 | 0.35 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.35 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1614779 | 1.00 | FABP7 (0.47) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL3286002 | 0.98 | FABP7 (0.45) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL3288497 | 0.94 | FABP7 (0.41) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL15611584 | 0.93 | FABP7 (0.54) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL5837269 | 0.91 | FABP7 (0.51) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL5837271 | 0.91 | FABP7 (0.51) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL31092875 | 0.84 | FABP7 (0.42) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL2140237 | 0.81 | ALDH1A1 (0.37) | FABP7FABP5TSHREPHX1LMNA | |
| SCHEMBL2137771 | 0.80 | ADRA2A (0.38) | FABP7FABP5CYP2C19CYP3A4TSHR | |
| SCHEMBL3367480 | 0.78 | MAPT (0.46) | EPHX1LMNAPOLBALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| CN-113316744-B | Oxime ester photoinitiators with special aroyl chromophores | 巴斯夫欧洲公司 | 2024-07-30 | — | — | CN | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-3044208-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-12-22 | — | — | EP | disclosed |
| WO-2021175855-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2021-09-10 | — | — | WO | disclosed |
| EP-3019473-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2016-05-18 | — | — | EP | disclosed |
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2016-03-03 | — | — | US | disclosed |
| WO-2016030790-A1 | OXIME SULFONATE DERIVATIVES | BASF SE (DE) | 2016-03-03 | — | — | WO | disclosed |
| WO-2015036910-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-03-19 | — | — | WO | disclosed |
| WO-2015004565-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2015-01-15 | — | — | WO | disclosed |
| EP-2668156-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2013-12-04 | — | — | EP | disclosed |
| WO-2012101245-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | BASF SE (DE) | 2012-08-02 | — | — | WO | disclosed |
| US-7713680-B2 | Radiation sensitive resin composition for forming a protective film, method of forming a protective film from the composition, liquid crystal display device and solid-state image sensing device | JSR CORPORATION (JP) | 2010-05-11 | — | — | US | disclosed |
| US-20080233515-A1 | RADIATION SENSITIVE RESIN COMPOSITION FOR FORMING A PROTECTIVE FILM, METHOD OF FORMING A PROTECTIVE FILM FROM THE COMPOSITION, LIQUID CRYSTAL DISPLAY DEVICE AND SOLID-STATE IMAGE SENSING DEVICE | JSR CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| EP-1972673-A1 | Radiation sensitive resin composition for forming a protective film, method of forming a protective film from the composition, liquid crystal display device and solid-state image sensing device | JSR Corporation (JP) | 2008-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060214-A1 | POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT | SULT1E1, COX6B1, SULT1A1 | FABP7 2679/4885FABP5 2078/4885CYP2C19 189/4885 |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | FABP7 513/4885FABP5 1164/4885CYP2C19 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.